**[미래에셋 제약/바이오 김승민]**
**10/13 Daily**

[https://t.me/bioksm](https://t.me/bioksm)


 **글로벌 바이오/제약**
────────────────────
 [BMS 폐질환 치료제 Admilparant, 후기 임상시험 ALOFT-IPF 임상시험에서 1차 평가변수를 충족](https://investors.bms.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Announces-Phase-3-ALOFT-IPF-Trial-Evaluating-Admilparant-in-Adults-with-Idiopathic-Pulmonary-Fibrosis-Met-Primary-Endpoint/default.aspx)

 [BMS, 레이즈바이오RayzeBio 신경내분비종양 방사성의약품 RYZ101 규제신청 계획](https://news.google.com/rss/articles/CBMi1gFBVV95cUxOZjlyckN6a0hCaTZRM2wxSUQ4OEcyQ0tfbVR5SkpMdHVXTms1N1BJNkpPZnRpYkxDR1hWS0t5OVh4NlNNdDJMdmhuMHNSRnU3aTlEbHNHZjlVOEFfdnRrcnN2THpEMFZURWhmNThEb0ItT1UxdFotMmc2M2w4VFo5MjNFenNGUkpUNVpGUFB1Rm1jVW5fcU5hOFJnWDUwTVR6dDh2cWdHN054MXVZRXNHUEdZZGZyeWZZTlY4Y1ctNW4wVE5Pc0otalBubEFlWXJodXBtYjZR?oc=5)

 [Merck, 당뇨병성 황반부종 치료제 루센티스 경쟁 제풍메 대한 엇갈린 임상 데이터 발표](https://endpoints.news/merck-reports-mixed-data-for-lucentis-competitor-in-diabetic-macular-edema/)

 [Lonza, Qurient의 CDK7 억제제에 대한 독점 접근권을 확보함으로써 이중페이로드 ADC 기술 제품군을 확장](https://www.lonza.com/news/2026-10-12-14-00)


 **한국 바이오/제약**
────────────────────
 [큐리언트, 론자와 이중 페이로드 ADC 플랫폼 공동사업화 계약 체결](https://www.medifonews.com/news/article.html?no=216723)

 [올릭스, 황반변성 치료제 'OLX10212' 뉴질랜드 2a상 신청 반려](https://www.hitnews.co.kr/news/articleView.html?idxno=79810)

 [알테오젠 "실탄 6300억, 새 기술 도입에 투자"](https://news.google.com/rss/articles/CBMiWkFVX3lxTE14MUFmUXJySFNmaGpxY2dlVkNBNTV0MVhTNmM0WWNHdmxlOFpjcmpVWWRneGh1UTB3NVJ1Zkx3RWVRZ041alpSdkRXRV9WZ1BzUzNmOGlLLWhkUQ?oc=5)

 [한미약품, 북경한미 900억원대 미회수채권 논란에 특별감사 착수](https://news.google.com/rss/articles/CBMibkFVX3lxTE11QlFxbVdla2JVaWlYWktYTHdDV0dycWJKZFl3cWZrOEFaZEF3MEptbFQ5ak9CMkU1OFpHNkVDWEJPR25FVTBDUm5OZ3ZySG9GYXJ6WTZCNlNJdTI0d0xNWm1aTVNud19qMk50UHdB?oc=5)

 [일동제약, 밀라노서 ‘수출·CMO·신약 기술이전’ 삼각 공략](https://news.google.com/rss/articles/CBMibkFVX3lxTE9qME1PZmF1dzBObGJFQmExaDgwX3k3V2pfSk1qeDNwUDZfc2JwRU5KTjAxak5JclVsOU9sSEdhdFN4bnBxYkFsZVBwTTJKM244OTJ6dEROM3pEQmJCdGRHcDBrb2RmcTlQWFhrdFpR?oc=5)

 ["케이캡, 미국 전향적 3상 임상서 가슴 쓰림·산 역류 개선 입증"](https://www.hitnews.co.kr/news/articleView.html?idxno=79795)

 [루닛, 글로벌 제약사 '디스커버리'와 차세대 신약 개발한다](https://news.google.com/rss/articles/CBMibkFVX3lxTE9XUE9OM3hUTDY1bk1qZTZDSjJIRDNPOHc4b1dNbnBkUnJBZ0s2TjlYSEpiMS1EdlNFeWZveXNWVVBwQkRfWVJZVncwdDJrMFFRZXd1X2xuTFE4dUNKak1hdVJWa2FQZVpCamh6S0Jn?oc=5)

 [동아에스티, 빈혈치료제 바이오시밀러 다베크론 UAE 출시](https://news.google.com/rss/articles/CBMiWkFVX3lxTE5aUEwwUjhqNlhfWUl6Y2ZDaUpjY3doc2pYR0FPQWVidGhpM3hXcUpMTXVISDVxSXp2XzBrMndEY0Uteko4bXMzdHFXdzdzVlN6cll4bnBaQmZfZw?oc=5)


────────────────────